Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Palesch

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Cell|November 19, 2013
First steps toward a globally effective HIV/AIDS vaccineDavid Palesch, Frank Kirchhoff
Applied and Environmental Microbiology|February 18, 2014
Prevention of contamination by xenotropic murine leukemia virus-related virus: susceptibility to alcohol-based disinfectants and environmental stabilityDavid Palesch, Mohammad Khalid, Christina M Stürzel, et al.
Journal of Virology|May 13, 2016
Initiation of Antiretroviral Therapy Restores CD4+ T Memory Stem Cell Homeostasis in Simian Immunodeficiency Virus-Infected MacaquesEmily K Cartwright, David Palesch, Maud Mavigner, et al.
Immunology Letters|May 12, 2009
Specific cathepsin B inhibitor is cell-permeable and activates presentation of TTC in primary human dendritic cellsMichael Reich, Ewa Wieczerzak, Elzbieta Jankowska, et al.
Plos One|September 24, 2013
Utilization of replication-competent XMRV reporter-viruses reveals severe viral restriction in primary human cellsChristina Martina Stürzel, David Palesch, Mohammad Khalid, et al.
Acta Biochimica Polonica|March 9, 2011
Was the serine protease cathepsin G discovered by S. G. Hedin in 1903 in bovine spleen?David Palesch, Marcin Sieńczyk, Jozef Oleksyszyn, et al.
Journal of Leukocyte Biology|January 30, 2010
A proinsulin 74-90-derived protease-resistant, altered peptide ligand increases TGF-beta 1 secretion in PBMC from patients with type 1 diabetes mellitusDenise van Aalst, Hubert Kalbacher, David Palesch, et al.
Chembiochem : a European Journal of Chemical Biology|May 31, 2016
PEGylated Cationic Serum Albumin for Boosting Retroviral Gene TransferDavid Palesch, Felix Boldt, Janis A Müller, et al.
Molecular Immunology|June 10, 2009
Protease-resistant human GAD-derived altered peptide ligands decrease TNF-alpha and IL-17 production in peripheral blood cells from patients with type 1 diabetes mellitusBernhard O Boehm, Silke Rosinger, Guido Sauer, et al.
Plos One|August 19, 2011
Regulation of cathepsin G reduces the activation of proinsulin-reactive T cells from type 1 diabetes patientsFang Zou, Nadja Schäfer, David Palesch, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cell|November 19, 2013
First steps toward a globally effective HIV/AIDS vaccineDavid Palesch, Frank Kirchhoff
Applied and Environmental Microbiology|February 18, 2014
Prevention of contamination by xenotropic murine leukemia virus-related virus: susceptibility to alcohol-based disinfectants and environmental stabilityDavid Palesch, Mohammad Khalid, Christina M Stürzel, et al.
Journal of Virology|May 13, 2016
Initiation of Antiretroviral Therapy Restores CD4+ T Memory Stem Cell Homeostasis in Simian Immunodeficiency Virus-Infected MacaquesEmily K Cartwright, David Palesch, Maud Mavigner, et al.
Immunology Letters|May 12, 2009
Specific cathepsin B inhibitor is cell-permeable and activates presentation of TTC in primary human dendritic cellsMichael Reich, Ewa Wieczerzak, Elzbieta Jankowska, et al.
Plos One|September 24, 2013
Utilization of replication-competent XMRV reporter-viruses reveals severe viral restriction in primary human cellsChristina Martina Stürzel, David Palesch, Mohammad Khalid, et al.
Acta Biochimica Polonica|March 9, 2011
Was the serine protease cathepsin G discovered by S. G. Hedin in 1903 in bovine spleen?David Palesch, Marcin Sieńczyk, Jozef Oleksyszyn, et al.
Journal of Leukocyte Biology|January 30, 2010
A proinsulin 74-90-derived protease-resistant, altered peptide ligand increases TGF-beta 1 secretion in PBMC from patients with type 1 diabetes mellitusDenise van Aalst, Hubert Kalbacher, David Palesch, et al.
Chembiochem : a European Journal of Chemical Biology|May 31, 2016
PEGylated Cationic Serum Albumin for Boosting Retroviral Gene TransferDavid Palesch, Felix Boldt, Janis A Müller, et al.
Molecular Immunology|June 10, 2009
Protease-resistant human GAD-derived altered peptide ligands decrease TNF-alpha and IL-17 production in peripheral blood cells from patients with type 1 diabetes mellitusBernhard O Boehm, Silke Rosinger, Guido Sauer, et al.
Plos One|August 19, 2011
Regulation of cathepsin G reduces the activation of proinsulin-reactive T cells from type 1 diabetes patientsFang Zou, Nadja Schäfer, David Palesch, et al.
Pageof 3